Christopher Mutz, the HEAD OF RARE DISEASE of $ANIP, sold 7,032 shares of the company on 02-12-2026 for an estimated $538,299. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.1% of their shares of this class of stock. Following this trade, they now own 92,566 shares of this class of $ANIP stock.
$ANIP Insider Trading Activity
$ANIP insiders have traded $ANIP stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $ANIP stock by insiders over the last 6 months:
- MUTHUSAMY SHANMUGAM (HEAD OF R&D, COO-NOVITIUM OPS) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $9,036,007.
- CHAD GASSERT (SVP - CORP. DEV. & STRATEGY) has made 0 purchases and 2 sales selling 14,736 shares for an estimated $1,312,434.
- ANTONIO R PERA has made 0 purchases and 2 sales selling 12,713 shares for an estimated $1,178,728.
- PATRICK D WALSH sold 8,643 shares for an estimated $750,903
- CHRISTOPHER MUTZ (HEAD OF RARE DISEASE) sold 7,032 shares for an estimated $538,299
- KRISTA DAVIS (SVP, CHIEF HR OFFICER) has made 0 purchases and 3 sales selling 4,385 shares for an estimated $392,302.
- MATTHEW J LEONARD sold 2,528 shares for an estimated $229,087
- MEREDITH COOK (SR. VP, GENERAL COUNSEL & SEC.) has made 0 purchases and 6 sales selling 2,600 shares for an estimated $223,805.
- RENEE P TANNENBAUM sold 1,800 shares for an estimated $146,070
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ANIP Hedge Fund Activity
We have seen 158 institutional investors add shares of $ANIP stock to their portfolio, and 119 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 938,631 shares (-93.5%) from their portfolio in Q3 2025, for an estimated $85,978,599
- UBS GROUP AG removed 439,095 shares (-74.4%) from their portfolio in Q4 2025, for an estimated $34,662,159
- POINT72 ASSET MANAGEMENT, L.P. added 399,092 shares (+inf%) to their portfolio in Q3 2025, for an estimated $36,556,827
- RUBRIC CAPITAL MANAGEMENT LP removed 343,414 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $27,109,101
- MACQUARIE GROUP LTD removed 291,129 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $22,981,723
- BALYASNY ASSET MANAGEMENT L.P. added 276,233 shares (+2785.7%) to their portfolio in Q3 2025, for an estimated $25,302,942
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 234,219 shares (+inf%) to their portfolio in Q3 2025, for an estimated $21,454,460
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ANIP Revenue
$ANIP had revenues of $227.8M in Q3 2025. This is an increase of 53.58% from the same period in the prior year.
You can track ANIP financials on Quiver Quantitative's ANIP stock page.
$ANIP Analyst Ratings
Wall Street analysts have issued reports on $ANIP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 11/10/2025
- JP Morgan issued a "Overweight" rating on 09/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 09/17/2025
To track analyst ratings and price targets for $ANIP, check out Quiver Quantitative's $ANIP forecast page.
$ANIP Price Targets
Multiple analysts have issued price targets for $ANIP recently. We have seen 5 analysts offer price targets for $ANIP in the last 6 months, with a median target of $115.0.
Here are some recent targets:
- Vamil Divan from Guggenheim set a target price of $124.0 on 01/16/2026
- Glen Santangelo from Barclays set a target price of $100.0 on 12/09/2025
- Gregory Fraser from Truist Securities set a target price of $90.0 on 10/09/2025
- Ekaterina Knyazkova from JP Morgan set a target price of $115.0 on 09/24/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $121.0 on 09/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
